These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 23893008)

  • 1. Multiple strategies to activate gold nanoparticles as antibiotics.
    Zhao Y; Jiang X
    Nanoscale; 2013 Sep; 5(18):8340-50. PubMed ID: 23893008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
    Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
    Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology as a therapeutic tool to combat microbial resistance.
    Pelgrift RY; Friedman AJ
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic platforms based on gold nanoparticles and their covalent conjugates with drug molecules.
    Vigderman L; Zubarev ER
    Adv Drug Deliv Rev; 2013 May; 65(5):663-76. PubMed ID: 22613038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From Nano to Micro: using nanotechnology to combat microorganisms and their multidrug resistance.
    Natan M; Banin E
    FEMS Microbiol Rev; 2017 May; 41(3):302-322. PubMed ID: 28419240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic gold: tethering of antimicrobial peptides to gold nanoparticles maintains conformational flexibility of peptides and improves trypsin susceptibility.
    Wadhwani P; Heidenreich N; Podeyn B; Bürck J; Ulrich AS
    Biomater Sci; 2017 Mar; 5(4):817-827. PubMed ID: 28275774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of antibiotics using small molecule variable ligand display on gold nanoparticles.
    Bresee J; Maier KE; Melander C; Feldheim DL
    Chem Commun (Camb); 2010 Oct; 46(40):7516-8. PubMed ID: 20835461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular mechanism of action of bactericidal gold nanoparticles on Escherichia coli.
    Cui Y; Zhao Y; Tian Y; Zhang W; Lü X; Jiang X
    Biomaterials; 2012 Mar; 33(7):2327-33. PubMed ID: 22182745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional gold nanoparticle-based antibacterial agents for nosocomial and antibiotic-resistant bacteria.
    Kuo YL; Wang SG; Wu CY; Lee KC; Jao CJ; Chou SH; Chen YC
    Nanomedicine (Lond); 2016 Oct; 11(19):2497-510. PubMed ID: 27622499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small molecule-capped gold nanoparticles as potent antibacterial agents that target Gram-negative bacteria.
    Zhao Y; Tian Y; Cui Y; Liu W; Ma W; Jiang X
    J Am Chem Soc; 2010 Sep; 132(35):12349-56. PubMed ID: 20707350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bimetallic nanoparticles against multi-drug resistant bacteria.
    Zhao X; Jia Y; Dong R; Deng J; Tang H; Hu F; Liu S; Jiang X
    Chem Commun (Camb); 2020 Sep; 56(74):10918-10921. PubMed ID: 32808607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plant extract mediated synthesis of silver and gold nanoparticles and its antibacterial activity against clinically isolated pathogens.
    MubarakAli D; Thajuddin N; Jeganathan K; Gunasekaran M
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):360-5. PubMed ID: 21466948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silver nanoparticle-embedded polymersome nanocarriers for the treatment of antibiotic-resistant infections.
    Geilich BM; van de Ven AL; Singleton GL; Sepúlveda LJ; Sridhar S; Webster TJ
    Nanoscale; 2015 Feb; 7(8):3511-9. PubMed ID: 25628231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mercaptopyrimidine-Conjugated Gold Nanoclusters as Nanoantibiotics for Combating Multidrug-Resistant Superbugs.
    Zheng Y; Liu W; Qin Z; Chen Y; Jiang H; Wang X
    Bioconjug Chem; 2018 Sep; 29(9):3094-3103. PubMed ID: 30063328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nano-therapeutics: A revolution in infection control in post antibiotic era.
    Zaidi S; Misba L; Khan AU
    Nanomedicine; 2017 Oct; 13(7):2281-2301. PubMed ID: 28673854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of coinage metal nanoclusters as antimicrobials to combat bacterial infections.
    Li D; Kumari B; Makabenta JM; Tao B; Qian K; Mei X; Rotello VM
    J Mater Chem B; 2020 Oct; 8(41):9466-9480. PubMed ID: 32955539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanomedicine: de novo design of nanodrugs.
    Yang Z; Kang SG; Zhou R
    Nanoscale; 2014 Jan; 6(2):663-77. PubMed ID: 24305636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gold/ampicillin interface at the atomic scale.
    Tarrat N; Benoit M; Giraud M; Ponchet A; Casanove MJ
    Nanoscale; 2015 Sep; 7(34):14515-24. PubMed ID: 26260342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era.
    Huh AJ; Kwon YJ
    J Control Release; 2011 Dec; 156(2):128-45. PubMed ID: 21763369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metal nanobullets for multidrug resistant bacteria and biofilms.
    Chen CW; Hsu CY; Lai SM; Syu WJ; Wang TY; Lai PS
    Adv Drug Deliv Rev; 2014 Nov; 78():88-104. PubMed ID: 25138828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.